Randomized, Double-Blind, Placebo-Controlled, Safety and Immunogenicity Study of 4 Formulations of Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909) in Healthy Adult Volunteers

A new anthrax vaccine that could accelerate the immune response and possibly reduce the number of injections needed for protection would be desirable in a post-exposure setting. This Phase 1 study compared the safety and immunogenicity of 2 IM doses (Days 0 and 14) of 4 formulations of AV7909 (AVA p...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hopkins, Robert J., Daczkowski, Nancy F., Kaptur, Paulina E., Muse, Derek, Sheldon, Eric, LaForce, Craig, Sari, Suha, Rudge, Thomas L., Bernton, Edward
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687017/
https://ncbi.nlm.nih.gov/pubmed/23701746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.04.063
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky